Simplex Trading’s Kindred Biosciences, Inc. KIN Stock Holding History

Simplex Trading’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-10,979	Closed	-$53K	–	10508
2020 Q4	$47K	Buy	10,979 +7,429	+209%	+$30.2K	﹤0.01%	6269
2020 Q3	$15K	Buy	+3,550	New	+$14.8K	﹤0.01%	6592
2020 Q1	–	Sell	-4,128	Closed	-$35.1K	–	8572
2019 Q4	$35K	Buy	+4,128	New	+$32.2K	﹤0.01%	5540
2019 Q3	–	Sell	-911	Closed	-$6.68K	–	8165
2019 Q2	$7K	Buy	+911	New	+$7.86K	﹤0.01%	6327
2015 Q3	–	Sell	-1	Closed	-$6	–	6453
2015 Q2	$0	Buy	+1	New	+$7	﹤0.01%	6097

Simplex Trading's KIN Position: Q1 2021 in Review

Simplex Trading sold out of Kindred Biosciences, Inc. (KIN) in Q1 2021, closing a stake of 10,979 shares — an estimated $53K sold.

Simplex Trading first reported a position in KIN in Q2 2015 and held it in 5 quarters. The position peaked at $47K in Q4 2020. 84 funds tracked by Wall St. Rank hold KIN as of Q1 2021.

Simplex Trading reported no remaining Kindred Biosciences, Inc. position as of Q1 2021 after selling out during the quarter.
Simplex Trading sold 10,979 Kindred Biosciences, Inc. shares in Q1 2021, an estimated $53K.
Simplex Trading first reported a position in Kindred Biosciences, Inc. in Q2 2015 and held it in 5 quarters.
Simplex Trading's Kindred Biosciences, Inc. position peaked at $47K in Q4 2020.
84 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q1 2021.

Based on Simplex Trading's 13F filing for Q1 2021, filed 26 Apr 2021.